Nerissa T. Viola
-
- Radiopharmaceutical Chemistry and Applications 20
- Monoclonal and Polyclonal Antibodies Research 10
- Medical Imaging Techniques and Applications 7
- Oncology top 10%
- HER2/EGFR in Cancer Research 5
- Cancer Immunotherapy and Biomarkers 3
-
- Medical Imaging and Pathology Studies 4
-
- Immunotherapy and Immune Responses 4
-
- Advanced biosensing and bioanalysis techniques 3
Nerissa T. Viola
39 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Radiology, Nuclear Medicine and Imaging 563
- Oncology 446
- Cancer Research 108
- Biomaterials 77
- Pulmonary and Respiratory Medicine 191
Countries citing papers authored by Nerissa T. Viola
This map shows the geographic impact of Nerissa T. Viola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nerissa T. Viola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nerissa T. Viola more than expected).
Fields of papers citing papers by Nerissa T. Viola
This network shows the impact of papers produced by Nerissa T. Viola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nerissa T. Viola. The network helps show where Nerissa T. Viola may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nerissa T. Viola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 16 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 35 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 53 | |
| 14 | 2019 | 1 | |
| 15 | 2018 | 73 | |
| 16 | 2018 | 39 | |
| 17 | 2017 | 33 | |
| 18 | 2013 | 53 | |
| 19 | 2013 | 79 | |
| 20 | 2008 | 69 |
About Nerissa T. Viola
Nerissa T. Viola is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Biological Psychiatry, Pulmonary and Respiratory Medicine and Cancer Research, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (20 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Medical Imaging Techniques and Applications (7 papers), HER2/EGFR in Cancer Research (5 papers), Immunotherapy and Immune Responses (4 papers), Medical Imaging and Pathology Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (563 citations), Oncology (446 citations), Cancer Research (108 citations), Biomaterials (77 citations) and Pulmonary and Respiratory Medicine (191 citations). Nerissa T. Viola has collaborated with scholars based in United States, Denmark and Poland. Frequent co-authors include Robert P. Doyle, Jason S. Lewis, Sean Carlin, Amy E. Rabideau, Jon Zubieta, Heather M. Gibson, Claire E. McCarthy, Michael J. Evans, Kuntal K. Sevak and Jacob L. Houghton. Their work appears in journals such as Molecular Pharmaceutics, Journal of Nuclear Medicine, Scientific Reports, Frontiers in Immunology and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.